IMNM
#1836
Immunome, Inc. - Common Stock
22.9 2 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.46%
Monthly Change
+27.12%
6 month change
+0.26%
Year Change
+167.44%
Previous Close
22.5 9
Open
22.8 2
Low
22.7 3
High
22.9 7
Volume
925
Financials
- Market Capitalization 2.6 B
- Employee 177
- Founded 2006
- CEO N/A
- Website www.immunome.com
- Headquarter Delaware, United States
- FIGI BBG00BR93ZG8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.15
Price to sales ratio
112.46
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1756 |  IRON Disc Medicine, Inc. - Common Stock | 76.11 USD | +1.47% | -4.93% | +10.21% | +31.25% | 2.91 B USD | ||
| 1828 |  KOD Kodiak Sciences Inc - Common Stock | 42.43 USD | -1.92% | +4.43% | +24.46% | +773.05% | 2.66 B USD | ||
| 1837 |  QURE uniQure N.V. - Ordinary Shares | 41.07 USD | -1.08% | -5.56% | +48.11% | +191.90% | 2.59 B USD | ||
| 1850 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 18.15 USD | +1.34% | -2.37% | +23.72% | +164.58% | 2.58 B USD |
Frequently asked questions about Immunome, Inc. - Common Stock
What is the Immunome, Inc. - Common Stock stock price today?
The current price of Immunome, Inc. - Common Stock (IMNM) is 22.92. Over the past 24 hours, the stock has changed by +1.46%. Follow the IMNM chart for real-time price dynamics.
What is the stock ticker of Immunome, Inc. - Common Stock?
Immunome, Inc. - Common Stock trades under the ticker IMNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunome, Inc. - Common Stock stock going up?
IMNM has changed by -4.54% over the last week, +27.12% over the last month, and +167.44% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immunome, Inc. - Common Stock net income for the last quarter?
Immunome, Inc. - Common Stock reported net income of -53.84 M for the last quarter. The previous quarter showed -69.9 M, which means net income changed by +22.98%.
How many employees does Immunome, Inc. - Common Stock have?
As of the latest available data, Immunome, Inc. - Common Stock has 177 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immunome, Inc. - Common Stock EBITDA?
Immunome, Inc. - Common Stock EBITDA is -53.24 M, and its EBITDA margin is -969.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immunome, Inc. - Common Stock stock?
You can buy Immunome, Inc. - Common Stock (IMNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunome, Inc. - Common Stock stock?
Investing in Immunome, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMNM chart and related analysis on metatrader.com as part of your research.